Dr. Arun Kumar Singh is an assistant professor in the Department of Pharmacy at Vivekanand Global University, Jaipur. He completed both his MPharm in Pharmaceutics and his PhD at Galgotias University, Greater Noida. His research strengths lie in AI-driven cancer research, nano-formulation, and the intersection of blockchain, IoT, machine learning, big data, and neuroscience with pharmaceutical science. He has authored books and contributed chapters on big data and cancer, and his work includes reviews published in reputable journals. His research appears across publishers such as IOP, Elsevier, CRC Press, and Wiley, reflecting a broad publication record and ongoing contributions to AI-enabled oncology and advanced drug delivery. Dr. Vipan Kumar is an Associate Professor at the School of Pharmaceutical Sciences, CGC University, Mohali, India. He received his PhD in Pharmaceutical Sciences from Maharshi Dayanand University, Rohtak. His research focuses on medicinal chemistry, nanotechnology-based drug delivery, and the development of novel therapeutic agents for cancer and metabolic disorders. He has published extensively in peer-reviewed journals, authored and edited several books and international volumes, including Elsevier publications, and contributed book chapters. He also holds multiple Indian patents in drug discovery and nanomedicine. He serves as an editorial board member and reviewer for international journals, delivers several talks and poster presentations at conferences, and is actively involved in CCSEA-related ethical committees and university Boards of Studies.Dr. Prabhakar is a Professor and Head in the Department of Biotechnology at Nagaland University, Kohima, India. He has been recognized among leading global scientists by Stanford’s annual Top Scientists list. He earned his PhD in Biotechnology from IIT Madras. His research centers on molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders using natural products. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society, and contributes as an editorial board member and reviewer for multiple journals. Dr. Prabhakar has received honors including a travel grant to a European conference supported by IIT Madras and CSIR, and funding approved by the Department of Science and Technology. He has published a substantial body of work, authored or edited several books, contributed many chapters, and given numerous talks and poster presentations at conferences. Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana. She earned a Master’s from NIPER Mohali and a PhD from IIT-BHU Varanasi, focusing on medicinal chemistry and CNS drug delivery targeting serotonin receptors. Her research encompasses targeted therapies such as JAK-STAT inhibitors, signaling pathways in health and disease, synthetic and heterocyclic chemistry, nanotechnology-enabled drug delivery, prodrug design, and herbal drug extraction. She has published extensively, holds multiple patents, and contributed to and edited scholarly books and chapters. An active presence at national and international conferences, she has secured competitive grants from major funding agencies. Dr. Dhanawat's work advances pharmaceutical science and education, reflecting a strong commitment to innovation, mentorship, and translational research.Dr. Neeraj Mishra is a Professor at the Amity Institute of Pharmacy, Gwalior, where he has served since July 2019. He has over 20 years of teaching and research experience and more than 150 international and national publications in novel, localized, targeted, and controlled drug delivery systems, including nano- and microparticles for the treatment of breast and colon cancer and neurodegenerative disorders. Dr. Mishra has authored 25 books and 45 book chapters with leading publishers such as Elsevier, Bentham, Springer, and Wiley, and holds five patents (three international and two Indian). His honors include the Distinguished Professor Awards (2019, 2021), Outstanding Scientist Award (2020), and Best Academician Award (2023). In 2025, he was recognized as one of the World’s Top 2% Scientists by Stanford University and Elsevier.
